Nicholas Butowski, MD, Neurology, Concord, CA, UCSF Medical Center

NicholasAButowskiMD

Neurology Concord, CA

Neurooncology

Professor of Clinical Neurological Surgery, UCSF School of Medicine

Dr. Butowski is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Butowski's full profile

Already have an account?

Education & Training

  • UCSF Medical CenterFELLOWSHIP
  • UCSF Medical Center
    UCSF Medical CenterRESIDENCY
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityINTERNSHIP
  • University of Illinois College of Medicine
    University of Illinois College of MedicineMEDICAL_SCHOOL
  • Northwestern UniversityOTHER_TRAINING

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2022
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Essential Core Teaching Award UCSF, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Voice of the Patient Award UCSF, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Single-institution Phase II Trial of Radiation, Temozolomide, Erlotinib, and Bevacizumab for Initial Treatment of Glioblastoma  
    Clarke, J.L., Molinaro, A.M., Butowski, N.A., Chang, S.M., Phillips, J.J., Perry, A., Costello, J.F., DeSilva, A.A., Rabbitt, J.E., Prados, M.D., Neuro Oncol., 1/1/2014
  • General and Neurological Complications of Targeted Therapy  
    Butowski NA, Chang SM, Handbook of Clinical Neurology, 1/1/2012
  • Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients with Advanced Solid Tumors  
    Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, Chinnaiyan P, et al., Journal of Clinical Oncology, 1/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • OMX-4.80 An Engineered Oxygen Carryig Protein Oxygenetes Hypoxic Tumors and Increase the Efficacy of Radiotherapy in Orthotopic Models of Glioblastoma
    Laura Serwer, Raquel Santos, Saharh Ng, Nicholas Butowski, Ana Krloitica, Tomoko OZawa, Stephen Cary, David James, World Federation of Neuro-Oncology Quadrennial Meeting, San Francisco, CA, 1/1/2014
  • A Phase 2 Study of Orally Administered PLX3397 in Patients With Recurrent Glioblastoma
    N. Butowski, H. Colman, J. DeGroot A. Yung, A. Omuro, L. Nayak, T. Cloughsey, A. Marimuthu, A. Perry , J. Phillips , J. Joyce , B. L. West , M. Prados , K. Nolop, H..., ASCO Annual Meeting, 1/1/2014
  • Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioblastoma Multiforme (GBM).
    Kent C. Shih, Manish R. Patel, Nicholas A. Butowski, Jeffrey A. Bacha, Dennis Brown, William J. Garner, Anne Steino, Richard Stephen Schwartz, Sarath Kanekal, Lorena L..., ASCO Annual Meeting, 1/1/2014
  • Join now to see all

Lectures

  • DGM1 may serve as a novel genetic biomarker of response to enzastaurin in glioblastoma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Overcoming Tumour Hypoxia to Enhance Patient Survival With a Tunable Oxygen-Binding Protein Therapy 
    United Kingdom - 1/1/2014
  • ICBTRT: International Conference on Brain Tumor Research and Therapy 
    1/1/2014
  • Join now to see all

Press Mentions

  • DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
    DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083November 06, 2019 22:12
  • Denali's Transport Vehicle Platform Holds Promise Beyond Neurodegenerative Disease
    Denali's Transport Vehicle Platform Holds Promise Beyond Neurodegenerative DiseaseSeptember 24, 2019 04:51
  • DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
    DelMar Pharmaceuticals Announces Expansion of Scientific Advisory BoardMay 20, 2019 22:04
  • Join now to see all

Professional Memberships

Hospital Affiliations